个人化药物在壮症:从ACROFAST临床试验的见解
Marta Araujo-Castro1,2, Betina Biagetti3, Víctor Navas-Moreno4,5
1Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Expert review of endocrinology & metabolism
|September 29, 2025
概括
个性化医学通过使用预测标志物来改善缩症治疗,以更快地实现生化控制. 人工智能和机器学习的进步进一步增强了个性化的治疗策略,以获得更好的患者结果.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 药物基因组学 药物基因组学
背景情况:
- 个性化医疗对于巨病的管理至关重要,它利用瘤分类,分子分析和先进的成像.
- 目前的指导方针经常建议使用第一代体静止素受体配体 (fgSRLs) 的试错方法,这种方法效率较低.
研究的目的:
- 审查最近在个人化药物对壮症的进步.
- 专注于手术和医疗治疗反应的预测标记.
- 重点介绍ACROFAST临床试验对个性化治疗策略的见解.
主要方法:
- 综述当前关于个人化医学在壮症的文献.
- 对治疗反应的预测标志物的分析.
- 检查来自ACROFAST临床试验的数据.
主要成果:
- 个性化医疗方法比传统方法更频繁,更快速地实现生化控制.
- 预测性生物标志物,如ACROFAST所示,增强治疗结果,改善生化缓解率.
- ACROFAST试验为实施个性化治疗策略提供了宝贵的见解.
结论:
- 个性化医学的持续进步是未来壮症研究的关键.
- 结合预测性生物标志物可以显著改善治疗结果,缩短随访时间.
- 人工智能和机器学习可以进一步完善药理管理,减少试错方法.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225


